Abrams Bison Investments trimmed its position in medical technology company Teleflex by 20.7% during the second quarter of 2026. According to its quarterly 13F filing, the firm sold over 200,000 shares, reducing its holding to 793,000. The stake was valued at approximately $100.5 million as of June 30. It's important to note that 13F filings are delayed disclosures reflecting a fund's holdings at the end of a quarter, so this trade occurred between April 1 and June 30.
During the second quarter, Teleflex completed a major divestiture of its OEM business and saw strong performance in its Vascular and Surgical units, though it also faced challenges integrating a recent acquisition. The company lowered its full-year revenue growth projections but raised its adjusted earnings per share guidance. Abrams Bison has not publicly commented on its reasons for the trade.